Chico, CA (PRWEB) October 30, 2013
Nearly 100,000 people die each year from preventable Nosocomial infections according to public health reports from March-April 2007 (http://www.infectionpreventiontextiles.com/HAI-101.php). Infections from Staphylococcus species including MRSA are a worldwide concern; the bacteria often colonize and infect patients in hospital and healthcare settings. The Virginia Department of Health states that 25-30%of all people carry Staph including MRSA in their nose (http://www.vdh.virginia.gov/Epidemiology/Surveillance/MRSA/). The bacteria spreads through sneezing, wiping a runny nose, touching the nose or using a nasal cannula. Despite steps taken to reduce the spread of these infections, they still remain a threat to the health and safety of everyone. In March of 2009 the Economist Division of Healthcare cited that more than $45 billion is spent annually treating preventable infections including Staph & MRSA (http://www.infectionpreventiontextiles.com/HAI-101.php).
A simple idea sparked a revolutionary new medical product that helps reduce the spread of Staph infections associated with MRSA or similar infectious bacteria when using nasal cannulas. The Infection Prevention Pouch (IPP) is a new microbiostatic breathable pouch that provides a protective holding space for nasal cannulas when not in use. This product reduced respiratory infections by 75% when compared to the current practice of using plastic bags in a study done in April of 2012 at Country Villa Riverview in Susanville, CA.
A different control group study took place from January 23, 2013 to March 25, 2013 and was performed at Sandpiper Premier Senior Living “SNF” under the direction of Eric Hadley, Executive Director (http://ncpcorp.com/app.php). The study was conducted to discover if the Infection Prevention Pouch (IPP) could be used to reduce upper respiratory infections (URI's). The study parameters compared the URI’s in residents storing their Nasal Cannula in a plastic bag versus a subset of those residents who stored their Nasal Cannula in the IPP.
It was found that the IPP had reduced URI's by 50% from the previous two month, however, those who continued to use a plastic bag experienced a 27% increase (http://ncpcorp.com/app.php). After the study was completed Hadley was quoted saying: "It certainly appears that the bags decrease overall rates of infection and specifically in those individuals who historically experience recurring infection. Considering price to value and outcomes, it certainly makes sense to use the bags."
“The IPP is a must-have for all medical facilities and home-care environments; nurses, doctors, and administrators need to know about it. This product saves lives by reducing the growth and spread of infections like Staph and MRSA,” says charge nurse and NCP founder, Meredith Lloyd.
The Infection Prevention Pouch (IPP) is new, convenient, cost effective, and easy to use. The IPP adheres to oxygen concentrators, wheelchairs, bedside tables and hospital beds for easy accessibility. When the IPP needs to be changed or removed, it leaves no residue behind.
This new Infection Prevention Pouch is a simple, inexpensive product that saves time, saves money, and saves lives.
About Nosocomial Containment Products, Inc.
Nosocomial Containment Products, Inc. (NCP Corp.) was formed to promote the Infection Prevention Pouch (IPP), which greatly reduces or eliminates the risk of cross-contamination to patients from the use of nasal cannulas and HHNs during their stay at medical facilities when compared to the use of plastic bags.
For additional information about the IPP and its ability to reduce or eliminate Staph & MRSA, visit http://www.ncpcorp.com/ or contact: NCP Corp., 1124 Almond Vista Ct., Chico, CA 95926 1-888-587-7775